Drugs / Diosmin-Hesperidin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07300735 | Mar 2025 → Mar 2027 expected | hematopoietic and lymphoid cell neoplasm, neutropenia | Alexandria University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diosmin-Hesperidin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07300735 ↗ |
| Route | Oral | “Diosmin-Hesperidin 500 mg oral tablet administered twice daily” NCT07300735 ↗ |